Weekly Digest – November 2024 Weekly Digest – November 2024 07 Nov 2024: ADC Therapeutics axes lead solid tumor drug after phase 1 setback, pivots to preclinical programs ADC Therapeutics has stopped the development of its lead solid tumor candidate, […]
Weekly Digest – November 2024 Weekly Digest – November 2024 06 Nov 2024: NextCure reports preclinical data for LNCB74 and additional clinical biomarker data for NC410 combo at Society for Immunotherapy of Cancer Annual Meeting NextCure announced preclinical data for […]
Weekly Digest – November 2024 Weekly Digest – November 2024 06 Nov 2024: Celltrion unveils development of two cancer drugs Celltrion unveiled two new ADC candidates, CT-P70 and CT-P71, at the World ADC 2024 conference, marking its first public disclosure […]
Weekly Digest – November 2024 Weekly Digest – November 2024 06 Nov 2024: MacroGenics pauses work on vobra duo ADC pending mature survival data MacroGenics has paused investment in vobra duo and related studies pending updated data from the Phase […]
